Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
237.60
+24.60 (11.55%)
At close: Apr 24, 2026

HKG:2637 Revenue

In the year 2025, Fujian Haixi Pharmaceuticals had annual revenue of 582.36M CNY with 24.79% growth.

Revenue
582.36M CNY
Revenue Growth
+24.79%
P/S Ratio
25.87
Revenue / Employee
3.55M CNY
Employees
164
Market Cap
16.76B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025582.36M115.68M24.79%
Dec 31, 2024466.68M150.05M47.39%
Dec 31, 2023316.63M104.17M49.03%
Dec 31, 2022212.47M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition